| Date Filed | Type | Description |
| 02/21/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 5,823 shares
@ $0.8415, valued at
$4.9k
|
|
| 02/14/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 287,544 options to buy
@ $0.8407, valued at
$241.7k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 7,027 shares
@ $0.6974, valued at
$4.9k
|
|
| 01/23/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 6,839 shares
@ $0.7166, valued at
$4.9k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 20,000 shares
@ $0.7398, valued at
$14.8k
|
|
| 08/22/2022 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 13,000 shares
@ $1.8511, valued at
$24.1k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |